Enhanced immunosuppression improves early allograft function in a porcine kidney transplant model of donation after circulatory death

Am J Transplant. 2019 Mar;19(3):713-723. doi: 10.1111/ajt.15098. Epub 2018 Sep 26.

Abstract

It remains controversial whether renal allografts from donation after circulatory death (DCD) have a higher risk of acute rejection (AR). In the porcine large animal kidney transplant model, we investigated the AR and function of DCD renal allografts compared to the non-DCD renal allografts and the effects of increased immunosuppression. We found that the AR was significantly increased along with elevated MHC-I expression in the DCD transplants receiving low-dose immunosuppression; however, AR and renal function were significantly improved when given high-dose immunosuppressive therapy postoperatively. Also, high-dose immunosuppression remarkably decreased the mRNA levels of ifn-g, il-6, tgf-b, il-4, and tnf-a in the allograft at day 5 and decreased serum cytokines levels of IFN-g and IL-17 at day 4 and day 5 after operation. Furthermore, Western blot analysis showed that higher immunosuppression decreased phosphorylation of signal transducer and activator of transcription 3 and nuclear factor kappa-light-chain-enhancer of activated B cells-p65, increased phosphorylation of extracellular-signal-regulated kinase, and reduced the expression of Bcl-2-associated X protein and caspase-3 in the renal allografts. These results suggest that the DCD renal allograft seems to be more vulnerable to AR; enhanced immunosuppression reduces DCD-associated AR and improves early allograft function in a preclinical large animal model.

Keywords: animal models: porcine; basic (laboratory) research/science; delayed graft function (DGF); donors and donation: donation after circulatory death (DCD); kidney transplantation/nephrology; rejection: acute.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Animals
  • Death
  • Delayed Graft Function / etiology
  • Delayed Graft Function / pathology
  • Delayed Graft Function / prevention & control*
  • Female
  • Graft Rejection / etiology
  • Graft Rejection / pathology
  • Graft Rejection / prevention & control*
  • Graft Survival / drug effects
  • Graft Survival / immunology*
  • Immune Tolerance / immunology*
  • Immunosuppression Therapy*
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / adverse effects*
  • Swine
  • Tissue Donors
  • Tissue and Organ Procurement / methods

Substances

  • Immunosuppressive Agents